CD8A and COVID-19: Although the absolute number of CD8+ T cells decreases in patients with severe COVID-19, the increased proportion of granzyme B and perforin produced via effector CD8+ T cells provides evidence of elevated cytotoxicity induced in severe patients (67, 68).